Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

August 15, 2020; Volume 17,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Basho, Reva

    1. You have access
      COVID-19 in cancer patients: risk, clinical features, and management
      Cuiwei Liu, Yanxia Zhao, Derick Okwan-Duodu, Reva Basho and Xiaojiang Cui
      Cancer Biology & Medicine August 2020, 17 (3) 519-527; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0289
  2. Buya, Suhaimee

    1. You have access
      Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer
      Keson Trakunram, Pichitpon Chaniad, Sarayut Lucien Geater, Warangkana Keeratichananont, Voravit Chittithavorn, Sumonmal Uttayamakul, Suhaimee Buya, Pritsana Raungrut and Paramee Thongsuksai
      Cancer Biology & Medicine August 2020, 17 (3) 652-663; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0063
  3. Cao, Zhe

    1. You have access
      MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy
      Zhe Cao, Jiangdong Qiu, Gang Yang, Yueze Liu, Wenhao Luo, Lei You, Lianfang Zheng and Taiping Zhang
      Cancer Biology & Medicine August 2020, 17 (3) 569-582; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0033
  4. Chaniad, Pichitpon

    1. You have access
      Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer
      Keson Trakunram, Pichitpon Chaniad, Sarayut Lucien Geater, Warangkana Keeratichananont, Voravit Chittithavorn, Sumonmal Uttayamakul, Suhaimee Buya, Pritsana Raungrut and Paramee Thongsuksai
      Cancer Biology & Medicine August 2020, 17 (3) 652-663; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0063
  5. Chen, Jiongyu

    1. You have access
      Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiation via downregulating frizzled class receptor 10
      Jiongyu Chen, Fan Zhang, Xiaosha Ren, Yahui Wang, Wenhe Huang, Jianting Zhang and Yukun Cui
      Cancer Biology & Medicine August 2020, 17 (3) 740-752; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0219
  6. Chen, Ling

    1. You have access
      Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
      Shaoping Shen, Ling Chen, Jialin Liu, Lin Yang, Mengna Zhang, Lingxiong Wang, Rong Zhang, Yasushi Uemura, Qiyan Wu, Xinguang Yu and Tianyi Liu
      Cancer Biology & Medicine August 2020, 17 (3) 555-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0027
  7. Chen, Luyue

    1. You have access
      TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma
      Yingbin Xie, Luyue Chen, Junhu Zhou, Chao Yang, Can Xu, Xiangyu Fan, Yanli Tan, Yanan Wang, Chunsheng Kang and Chuan Fang
      Cancer Biology & Medicine August 2020, 17 (3) 664-675; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0356
  8. Chen, Peng

    1. You have access
      An ATF24 peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment
      Bingtao Zhai, Peng Chen, Wengang Wang, Shuiping Liu, Jiao Feng, Ting Duan, Yu Xiang, Ruonan Zhang, Mingming Zhang, Xuemeng Han, Xiaying Chen, Qiujie Li, Guohua Li, Ying Liu, Xingxing Huang, Wenzheng Zhang, Ting Pan, Lili Yan, Ting Jin, Tian Xie and Xinbing Sui
      Cancer Biology & Medicine August 2020, 17 (3) 676-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0454
  9. Chen, Xiaying

    1. You have access
      An ATF24 peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment
      Bingtao Zhai, Peng Chen, Wengang Wang, Shuiping Liu, Jiao Feng, Ting Duan, Yu Xiang, Ruonan Zhang, Mingming Zhang, Xuemeng Han, Xiaying Chen, Qiujie Li, Guohua Li, Ying Liu, Xingxing Huang, Wenzheng Zhang, Ting Pan, Lili Yan, Ting Jin, Tian Xie and Xinbing Sui
      Cancer Biology & Medicine August 2020, 17 (3) 676-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0454
  10. Cheng, Xinxin

    1. You have access
      Zinc dysregulation in cancers and its potential as a therapeutic target
      Jie Wang, Huanhuan Zhao, Zhelong Xu and Xinxin Cheng
      Cancer Biology & Medicine August 2020, 17 (3) 612-625; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0106
« Previous (Pages : 1 2 3 4 5 6 ... 17) Next »
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 17 (3)
Cancer Biology & Medicine
Vol. 17, Issue 3
15 Aug 2020
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire